HROW News and Press, Harrow Health Inc. From 01/03/24

Melt Pharmaceuticals, Inc. (“Melt”), a clinical‑stage pharmaceutical company developing novel approaches for procedural sedation, today provided a corporate update. The Company previously announced that MELT-300 achieved the primary sedation endpoint in its Phase 2 Pivota...

Agreements Support the Upcoming Launch of VEVYE ® Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that it has partnered with three leading healthcare technology platforms to expand U.S. availability of VEVYE ® (cyclosporine ophthal...

2024-01-02 07:09:05 ET Summary The Bloomberg report alleging an investigation into Franchise Group, Inc. (FRG)'s CEO relates to a fraud case against one of his associates from a previous employment, unlikely to impact RILY or FRG. Management is committed to its $1 quarterly distri...

2023-12-24 13:08:45 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips While the concept of short-squeeze stocks has been all the rage throughout most of the pandemic-disruption cycle, we may have been doing this all wrong. Rather, it’s time to address this...

2023-12-13 02:40:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced the completion of the transfer to Harrow of the New Drug Application (NDA) for TRIESENCE ® (triamcinolone acetonide injectable suspension) 40 mg/mL, a synthetic corticosteroid indicated for the treatmen...

Harrow (Nasdaq: HROW), a leading U.S. eyecare pharmaceutical company, today announced that Mark L. Baum, Chief Executive Officer, and Andrew Boll, Chief Financial Officer, will participate in the following two upcoming conferences: BTIG 3 rd Annual Ophthalmology Day Format: Fi...

2023-11-17 14:58:48 ET Summary Strategies for generating passive income include income investing, real estate investment trusts, master limited partnerships, exchange-traded debt, bonds, value-add property, joint ventures/REITs, and peer-to-peer lending. Preferred stocks, REITs, M...

ATLANTA, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Harrow, Inc. (“Harrow” or the “Company”) (NASDAQ: HROW) complied with federal securities laws. On November 13, 2023, Harrow released its third quarter 2023 financial results re...

2023-11-15 00:33:34 ET Summary Harrow is a company focused on eye health with a strong distribution platform and CEO ownership. Q3 earnings were below expectations, and guidance was lowered, raising concerns about operational performance. However, the company has lots of oppor...